Hims & Hers Health, Inc. (HIMS) Stock Price, Financials & Summary

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$28.23

From 52W high−55.40%

Volume9.32M

Market cap$6.53B

P/E (TTM)—

P/S (TTM)2.5x

Div yield—

Key dataSep 18, 2026

Open

$28.23

From 52W high

−55.40%

Volume

9.32M

Market cap

$6.53B

ValuationView details →

P/E (Fwd)

138.8x

EV/EBITDA

−94.7x

P/E (TTM)

—

RSI (14)

45.6

MomentumView details →

1D Return

+0.36%

YTD Return

−13.80%

SummaryUpdated Jun 1, 2026

Hims & Hers Health, Inc. (NYSE:HIMS) is a San Francisco-based telehealth company that operates a multi-specialty digital health platform connecting consumers directly to licensed healthcare professionals. Founded in 2017, the company went public in 2019 and has rapidly expanded from its initial focus on men's sexual health to become a comprehensive telehealth provider serving over 2.4 million subscribers across multiple health specialties including weight management, dermatology, mental health, and sexual wellness.

Ask drillr about Hims & Hers Health, Inc. →

ValuationView details →

P/E (Fwd)

138.8x

P/E (TTM)

—

EV/EBITDA

−94.7x

EV/Sales

2.8x

P/S (TTM)

2.5x

P/B (TTM)

20.2x

ProfitabilityView details →

Gross Margin

64.68%

Net Margin

−5.51%

EBITDA Margin

−2.96%

ROE (TTM)

−43.83%

ROA (TTM)

−3.91%

Asset Turnover

0.87x

GrowthView details →

Revenue YoY

+28.04%

EPS YoY

—

FCF YoY

−24.79%

Revenue CAGR 3Y

+64.55%

EPS CAGR 3Y

−1.72%

EBITDA YoY

—

MomentumView details →

1D Return

+0.36%

YTD Return

−13.80%

1Y Return

−51.59%

RSI (14)

45.6

vs 50D SMA

−7.30%

vs 200D SMA

+0.03%

Capital & dividendView details →

Debt/Equity

4.77x

Current Ratio

0.93x

Quick Ratio

0.87x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.37

EPS Surprise

−643.12%

Beats (12Q)

6/12

Next Q EPS Est

$0.06

Avg Surprise (4Q)

−212.34%

Rev Surprise

7.77%

Financials snapshotView financials →

Revenue (TTM)

2.58B

Net Income (TTM)

−142.03M

Op. CF (TTM)

266.84M

Next earningsNov 9, 2026 →

Latest newsMore news →

Hims & Hers Health, Inc. (HIMS) closed at $27.93, down 3.07% from the previous trading day, falling more steeply than the broader market.5d ago

Similar companies

Concentra Group Holdings Parent, Inc.CON Envista Holdings CorpNVST Labcorp Holdings Inc.LH 艾隆科技688329.SH Brainaurora-b06681.HK Beta Bionics, Inc.BBNX Find similar companies →

Latest newsMore news →

A securities fraud class action lawsuit, Velanki v. Hims & Hers Health, Inc., was filed against Hims & Hers Health in the U.S. District Court for the Northern District of California over alleged misstatements about its privacy practices, with a November 2, 2026 deadline for lead plaintiff status.3d ago Hims & Hers Health, Inc. (HIMS) closed at $27.93, down 3.07% from the previous trading day, falling more steeply than the broader market.5d ago Hims & Hers Health Inc stock rose 6.6% to trade at $29.34.6d ago